产品编号 | CFN60056 | |
CAS编号 | 915019-65-7 | |
分子式 = 分子量 | C30H23N5O = 469.55 | |
产品纯度 | >=98% | |
物理属性 | Powder | |
化合物类型 | Alkaloids | |
植物来源 | ||
ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 |
产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 1mg | QQ客服:1413575084 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 5mg | QQ客服:1413575084 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 10mg | QQ客服:1413575084 |
Dactolisib (BEZ235) | CFN60056 | 915019-65-7 | 20mg | QQ客服:1413575084 |
Description: | Dactolisib (BEZ235, NVP-BEZ235) is a dual ATP-competitive PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM in cell-free assays, respectively. Inhibits ATR with IC50 of 21 nM in 3T3TopBP1-ER cell. Dactolisib induces autophagy and suppresses HIV-1 replication. |
Targets: | PI3K | mTOR | ATR | Autophagy | HIV |
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 2.1297 mL | 10.6485 mL | 21.297 mL | 42.594 mL | 53.2425 mL |
5 mM | 0.4259 mL | 2.1297 mL | 4.2594 mL | 8.5188 mL | 10.6485 mL |
10 mM | 0.213 mL | 1.0648 mL | 2.1297 mL | 4.2594 mL | 5.3242 mL |
50 mM | 0.0426 mL | 0.213 mL | 0.4259 mL | 0.8519 mL | 1.0648 mL |
100 mM | 0.0213 mL | 0.1065 mL | 0.213 mL | 0.4259 mL | 0.5324 mL |
产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
茶皂素; Saponin | CFN70204 | 8047-15-2 | C27H42O3 = 1645.2 | 20mg | QQ客服:1457312923 |
升麻环氧醇苷; Cimigenoside | CFN98340 | 27994-11-2 | C35H56O9 = 620.8 | 20mg | QQ客服:1413575084 |
Villosin; Villosin | CFN99674 | 160598-92-5 | C20H28O2 = 300.4 | 5mg | QQ客服:2159513211 |
Crucigasterin 275; Crucigasterin 275 | CFN00049 | 150151-84-1 | C18H29NO = 275.43 | 5mg | QQ客服:215959384 |